Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2021-08-26 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
《公司章程》修正案
Governance Information Classification · 95% confidence The document is a formal announcement from the board of directors of 健帆生物科技集团股份有限公司 regarding amendments to the company's Articles of Association (公司章程). It details changes in registered capital and share capital due to a repurchase and cancellation of restricted shares related to a stock incentive plan. The document mentions that the amendment requires shareholder approval at a general meeting. The content focuses on governance and corporate structure changes rather than financial results or reports. The document length is short (789 characters) and it is an announcement of changes to governance documents, not a full governance report or annual report. Therefore, the most appropriate classification is Governance Information (CGR).
2021-08-26 Chinese
关于回购公司股份方案的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from a company regarding a share repurchase plan. It details the purpose, conditions, price range, quantity, funding source, implementation period, and expected impact on the company's capital structure. It also includes risk warnings, management analysis, and authorizations related to the share buyback. The document does not contain financial statements or quarterly/yearly financial results but focuses on the company's plan to buy back its own shares. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2021-08-26 Chinese
关于召开2021年第三次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2021 third extraordinary general meeting of shareholders for a company, including meeting time, location, agenda items, voting procedures, and proxy forms. It does not contain financial statements or results but rather the announcement and procedural details for the shareholder meeting. The content focuses on the meeting notice and voting instructions, typical of a shareholder meeting announcement rather than a report or results document. The document length is about 4683 characters, which is consistent with a detailed meeting notice. Therefore, the document fits the category of AGM Information (AGM-R).
2021-08-26 Chinese
公司章程（2021年8月）
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association (章程) for 健帆生物科技集团股份有限公司. It covers the company's organizational structure, shareholder rights, board and management roles, share issuance and transfer rules, shareholder meeting procedures, and voting rules. It is a governance document that outlines internal rules and governance practices rather than a financial report, audit, or announcement. There is no indication that this is an annual report, earnings release, or any other financial filing. The content matches the description of Governance Information (CGR), which includes reports detailing the company's internal rules, board structure, and governance practices.
2021-08-26 Chinese
第四届董事会第二十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting of the company. It details the meeting date, attendance, and specific agenda items approved by the board, such as a share repurchase plan, authorization for handling repurchase matters, amendments to the company bylaws, and the scheduling of a shareholders meeting. The document does not contain financial statements or detailed financial data but rather reports on board decisions and approvals. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length is short (1850 characters), and it is not a report or presentation but a meeting resolution announcement. Therefore, the correct classification is MANG with high confidence.
2021-08-26 Chinese
独立董事关于第四届董事会第二十五次会议相关事项的独立意见
Transaction in Own Shares Classification · 95% confidence The document is an independent opinion from the independent directors regarding a share repurchase (buyback) plan by the company. It discusses the legality, rationale, and impact of the share repurchase scheme, confirming it complies with relevant laws and benefits shareholders. The document does not contain financial statements or detailed financial data but is a formal opinion related to a transaction in the company's own shares. Therefore, it fits the category of a Transaction in Own Shares (POS) filing rather than a full financial report or announcement of a report.
2021-08-26 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.